Welcome to the 2026 edition of the Clinical Trials Roundup. This year marks the 10th edition of this annual analysis, a decade of continuous coverage tracking the evolution of the pharmaceutical industry’s clinical trials landscape.
As in each prior edition, this year’s report draws on Trialtrove data to examine Phase I–III clinical trials that initiated in 2025, spanning all therapeutic areas comprehensively covered by the platform, with in-depth analysis of key diseases, sponsoring companies, and geographies.
